A Cytoplasmic Sequence in Human Tyrosinase Defines a Second Class of Di-leucine-based Sorting Signals for Late Endosomal and Lysosomal Delivery*

Paul A. CalvoDagger , David W. Frank§, Bert M. Bieler, Joanne F. Berson, and Michael S. Marks

From the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6082

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Distinct cytoplasmic sorting signals target integral membrane proteins to late endosomal compartments, but it is not known whether different signals direct targeting by different pathways. The availability of multiple pathways may permit some cell types to divert proteins to specialized compartments, such as the melanosome of pigmented cells. To address this issue, we characterized sorting determinants of tyrosinase, a tissue-specific resident protein of the melanosome. The cytoplasmic domain of tyrosinase was both necessary and sufficient for internalization and steady state localization to late endosomes and lysosomes in HeLa cells. Mutagenesis of two leucine residues within a conventional di-leucine motif ablated late endosomal localization. However, the properties of this di-leucine-based signal were distinguished from that of CD3gamma by overexpression studies; overexpression of the tyrosinase signal, but not the well characterized CD3gamma signal, induced a 4-fold enlargement of late endosomes and lysosomes and interfered with endosomal sorting mediated by both tyrosine- and other di-leucine-based signals. These properties suggest that the tyrosinase and CD3gamma di-leucine signals are distinctly recognized and sorted by distinct pathways to late endosomes in non-pigmented cells. We speculate that melanocytic cells utilize the second pathway to divert proteins to the melanosome.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The maintenance of morphological and functional integrity of individual compartments of the secretory and endosomal pathways requires proper sorting of integral membrane components. Eukaryotic cells have evolved mechanisms to divert specific integral membrane protein components from several sites into tubular and/or vesicular carriers destined for late endosomes and lysosomes (reviewed in Refs. 1 and 2). Most of these mechanisms require the recognition of specific sorting signals within the cytoplasmic domains of resident proteins by cytosolic factors. It is becoming increasingly clear, however, that there are redundant pathways to late endosomes and lysosomes in many eukaryotic cells. An example of this redundancy is observed in Saccharomyces cerevisiae, in which two apparently independent pathways with distinct effectors converge on the lysosome-like vacuole to deliver different sets of hydrolases and structural components (3, 4). Cargo selection for these two pathways relies on the recognition of distinct cytoplasmic sorting signals (5-8). Evidence also exists in mammalian cells for multiple pathways from the trans-Golgi network to late endosomes (9-13), but sorting signals required for entry into different pathways have not yet been clarified.

What advantage would be imparted to an organism by the evolution of independent pathways to late endosomes and lysosomes? For higher eukaryotes, one potential advantage would be the ability to subvert one pathway or the other in specific cell types to permit the development of unique, tissue-specific lysosome-like organelles. Such a strategy would be similar to that used to establish polarity in epithelial cells. Protein sorting to the basolateral and apical cell surfaces requires sorting signals that are recognized for packaging into distinct vesicular carriers in both polarized and non-polarized cells (14-16), but only in polarized cells are the vesicles targeted to different destinations (reviewed in Ref. 17). Whether comparable mechanisms act in protein sorting to other tissue-specific post-Golgi organelles is not known.

One tissue-specific organelle with the potential for accumulating a subpopulation of proteins diverted from the late endosome is the melanosome, the organelle of melanocytes in which melanin is synthesized (18, 19). Melanosomes resemble secretory lysosomes in that they are highly acidic and often co-fractionate with markers of late endosomes and lysosomes such as lamp1, lamp2, CD63, and acid phosphatase (20-23). Furthermore, genes that control coat color in mice and skin color in humans encode proteins that are involved in lysosomal biogenesis (24, 25). Nevertheless, melanosomes contain a unique cohort of resident membrane proteins and can be distinguished from late endosomes and lysosomes in some pigmented cells (26). Thus, resident proteins of both organelles must be differentially sorted, but the characteristics that distinguish between sorting to late endosomes/lysosomes and to melanosomes have not been established.

Perhaps the best characterized melanosomal resident protein in normal and malignant melanocytes is tyrosinase (reviewed in Ref. 28). Human tyrosinase, the rate-limiting enzyme in melanin biosynthesis, is a melanocyte-specific, type I integral membrane glycoprotein with a large lumenal domain, a 26-amino acid transmembrane domain, and a 30-amino acid cytoplasmic domain (Ref. 27; see Fig. 1 for schematic). Impairment of tyrosinase activity in humans results in oculocutaneous albinism (OCA1; Ref. 29). Among the many tyrosinase gene mutations that cause OCA or other pigmentation defects, two affect the cytoplasmic domain. The tyrosinase gene in mice homozygous for the cP (platinum) allele contains a single base substitution that eliminates all but the basic transmembrane anchor residues of the cytoplasmic tail; the product of this allele is therefore mistargeted and expressed at the cell surface (30). A similar mutation in human tyrosinase results in OCA (31), but the localization of the gene product in melanocytes from these patients has not been characterized. These reports suggest that the cytoplasmic domain of tyrosinase is critical for melanosomal protein sorting. Nevertheless, neither the precise nature of the sorting signals nor their behavior in non-pigmented cells is understood. Here, we explore the possibility that sorting signals with unique characteristics direct tyrosinase into a sorting pathway that is distinct from that used by typical residents of late endosomes and lysosomes.

The cytoplasmic domain of human tyrosinase contains several potential conventional sorting signals. Among these are sequences that conform to classic di-leucine-based (LL) motifs (E510KQPLL515) and tyrosine-based motifs of the YXXØ consensus sequence (in which a tyrosine, Y, is separated by two residues, X, from an amino acid containing a bulky hydrophobic side chain, Ø; Y521HSL524), both common among proteins localized to endosomal compartments (32-36). The cytoplasmic domain also contains a second tyrosine-containing sequence (Y525QSHL529) (see Fig. 1a). All three are conserved in mouse tyrosinase, and the LL motif and Tyr525 are conserved throughout vertebrate evolution. A role for the LL motif in melanosomal sorting is supported by a requirement of LL residues in tyrosinase related protein-1 (TRP-1) for intracellular localization (37) and by recent evidence that the LL motif from mouse tyrosinase can bind to the AP3 sorting complex in vitro (38). We postulated that some or all of these motifs may direct endosomal sorting in a non-pigmented cell type. Here, using a panel of chimeric proteins and tyrosinase constructs in which these putative sorting signals have been altered by mutagenesis, we characterize the trafficking of tyrosinase in non-pigmented cells. Our results show that the LL motif is a dominant signal that directs late endosomal sorting through a distinct pathway from that directed by another well characterized late endosomal LL-based signal. This suggests that non-pigmented cells contain a second independent sorting pathway to the late endosome. Such a pathway provides a potential mechanism by which melanocytic cells can differentially sort proteins to the melanosome.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 1.   Wild-type and mutant constructs of tyrosinase. a, schematic representation of the tyrosinase gene product showing the predicted signal sequence (SS), lumenal, transmembrane (TM), and cytoplasmic (Cyt) domains. The number of amino acid residues in each domain are indicated at the top. The amino acid sequence of the predicted wild-type cytoplasmic domain, beginning with the cysteine residue at position 500, is shown below with putative targeting determinants shown in bold. The sequence of the site-directed mutants, named for their amino acid substitution at the bold sites, are shown below. The transmembrane domain is defined as ending in the amino acid sequence LVSLL. b, schematic depiction of the domain structure of Tac/tyrosinase chimeras. The coding region for the cytoplasmic domain of tyrosinase was appended to that for the lumenal and transmembrane domains of Tac using a double PCR technique. The wild-type and mutant amino acid sequences of the cytoplasmic domains of Tac chimeric constructs are listed below. The transmembrane domain of Tac is defined here as ending in the amino acid sequence GLTWQ. c, schematic representation of Tac chimeras TTL1 and Tac-DKQTLL used in degradation and overexpression studies. The sequences of characterized tyrosine- and di-leucine-based sorting signals in the cytoplasmic domains are indicated. The sequence DKQTLL is derived from the CD3gamma chain.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Antibodies-- Wild-type and mutant forms of human tyrosinase were recognized by alpha PEP7h (39), a rabbit antiserum to the cytoplasmic domain (gift of V. Hearing, National Institutes of Health, Bethesda), or NY8K (40), a rabbit antiserum to the lumenal domain (gift of L. Old, Ludwig Institute for Cancer Research, New York). Chimeric proteins containing the lumenal domain of the interleukin-2 receptor alpha  chain (Tac) were detected using the mouse monoclonal antibody (mAb) 7G7.B6 (American Type Culture Collection, Rockville, MD) or a rabbit anti-Tac serum (41). Human invariant chain was detected using mAb LL-1 (gift of H. Hansen, Immunomedics, Inc., Morris Plains, NJ; Ref. 42) to the lumenal domain or PIN.1 (gift of P. Cresswell, Yale University, New Haven, CT; Ref. 43) to the cytoplasmic domain. The following lists endogenous cellular proteins and reagents used to detect them: lamp1, mAb H4A3 (Developmental Studies Hybridoma Bank, University of Iowa, Iowa City) or a rabbit anti-lamp1 serum (gift of M. Fukuda, Scripps Research Institute, San Diego CA) (44, 45); lamp2, mAb H4B4 (Developmental Studies Hybridoma Bank); transferrin receptor, mAb B3/25 (Boehringer Mannheim); and cation-independent mannose 6-phosphate receptor, rabbit anti-MPR300 serum (gift of T. Braulke, University of Göttingen, Germany). FITC, lissamine rhodamine (LRSC), and phycoerythrin (PE)-conjugated secondary antibodies were purchased from Jackson ImmunoResearch (West Grove, Pennsylvania).

Cell Culture and Transfections-- HeLa, CV-1, 293, and M1 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 10% heat-inactivated fetal bovine serum (Atlanta Biologics, Norcross, GA) and antibiotics (100 units/ml penicillin, 100 µg/ml streptomycin). Transient transfections of cells grown on coverslips in 6 well dishes were performed essentially as described (46) using calcium phosphate precipitation. Except for overexpression studies, 50-100 ng of "expressor" plasmid DNA was used, and the balance was made up with "carrier" plasmid (empty pCDM8.1 vector) to 5 µg total; pilot studies showed that this protocol allowed detectable expression of previously characterized lysosomally targeted proteins without significant overexpression, as assessed by surface expression. Cells were generally assayed 2-3 days following transfection. For overexpression and competition experiments, cells were plated in 60- or 100-mm dishes and transfected with 8 or 20 µg of DNA, respectively.

Plasmids-- The R402Q allele of human tyrosinase was supplied in the mammalian expression vector pCI (Promega, Madison, WI) by W. Storkus (University of Pittsburgh, Pittsburgh). Wild-type human tyrosinase 501 (gift of S. Topalian, National Cancer Institute, Bethesda), originally inserted into pCDNA3, was subcloned into pCDM8.1 using EcoRI and XbaI restriction sites. Original site-directed mutants were constructed using the tyrosinase R402Q construct, but due to apparent misfolding in cells grown at 37 °C,2 the R402Q substitution was corrected and the corrected form was used in all experiments shown. Correction was performed by PCR-mediated amplification of the site-directed mutants of tyrosinase R402Q sequences downstream of the allelic variation (coding region for the remaining lumenal domain fragment and the transmembrane and cytoplasmic domains) and substitution of the amplicon into wild-type tyrosinase 501 cDNA using BglII and XbaI restriction enzyme sites. The nucleic acid sequence of all constructs was confirmed by dideoxynucleotide sequencing. The plasmids pCDM8.1 (47), human invariant chain p33 (Ip33; Ref. 48), Tac (49) and the chimeric constructs TTMb (46), TTL1 (50), and Tac-DKQTLL (originally referred to as TTgamma t3-t2; Ref. 51), all cloned into pCDM8.1, have been previously described.

Site-directed Mutagenesis-- Most site-directed mutants of the cytoplasmic tail of tyrosinase (see Fig. 1a) were constructed using the GeneEditor in vitro Mutagenesis System (Promega, Madison, WI) according to the directions of the supplier (details available upon request). Constructs in which Tyr525 (XX/X/A) was mutated were made by PCR-mediated amplification of the wild-type or previously mutated sorting signals followed by sub-cloning of the amplicon using a unique BglII recognition site in the tyrosinase coding region and an XbaI site in the vector. Delta tail-1 and Delta tail-2 were made by insertion of a single PCR amplicon from the original construct. Plasmid DNA was screened for a unique restriction enzyme digestion pattern relative to the wild type, and sequences of mutants were confirmed by dideoxynucleotide sequencing.

Construction of Tac Chimeras-- All Tac chimeric constructs were prepared as described (46) in the mammalian expression vector pCDM8.1. Tac chimeras were generated for all constructs listed in Fig. 1 using a two-step PCR method (52). Briefly, a chimeric insert was made encoding the lumenal and transmembrane domains of Tac fused to the cytoplasmic domain of tyrosinase flanked by unique BglII and XbaI restriction sites. The chimeric insert was then ligated into a previously modified Tac chimeric construct. DNA sequences of all chimeric constructs were confirmed by dideoxynucleotide sequencing.

Immunofluorescence Microscopy-- Forty-eight hours following transfection, cells were fixed using 2% formaldehyde in PBS for 20 min at room temperature and washed with PBS. In some cases, cells were treated with cycloheximide (CHX; 50 µg/ml) for 1 h in Dulbecco's modified Eagle's medium and washed in PBS prior to fixation. Cells that had been transfected with DNA encoding Tac chimeric proteins were either untreated or treated with 1 mg/ml leupeptin for 4 h prior to fixation. Cells were stained as described (53). Stained coverslips were mounted on microscope slides using Fluoromount-G (Southern Biotechnology Associates, Birmingham, AL) and visualized by fluorescence microscopy using a Zeiss Axiovert microscope. Photographic images were digitized from negatives using a Nikon LS-1000 slide scanner and Adobe Photoshop 3.0 software. For overexpression studies and measurement of late endosomal diameter, analyses were done using a Leica microscope fitted with a MicroMax digital camera (Princeton Instruments Inc., Trenton, NJ) and OpenLab software (Improvision, Coventry, UK). Statistical analyses of endosomal diameter measurements was performed using the Mann-Whitney Rank Sum Test on SigmaStat software (Jandel Scientific, San Rafael, CA).

Metabolic Labeling and Immunoprecipitation-- HeLa cells transiently transfected with Tac chimeras or tyrosinase and/or Ip33 were metabolically labeled using 1-2 mCi/ml EXPRES35S (NEN Life Science Products) for 30 min as described (50). Cell lysates prepared with 1% Triton X-100 were subjected to immunoprecipitation using protein A-Sepharose bound to 7G7.B6 (anti-Tac), PIN.1 (anti-Ip33), or alpha PEP7h (anti-tyrosinase) as described (50), except that lysates were first normalized for radioactive label content by trichloroacetic acid precipitation from lysate aliquots. Immunoprecipitates were fractionated by SDS-PAGE on 10% polyacrylamide gels, and radioactive bands were quantitated using a Molecular Dynamics PhosphorImager and ImageQuant software (Sunneyvale, CA). Average expression per cell was calculated by dividing the total radioactivity in precipitable bands by the transfection efficiency (fraction of positively stained cells by immunofluorescence microscopy).

Antibody Internalization Assay-- HeLa cells transiently transfected with Tac chimeras on coverslips were incubated with purified 7G7.B6 anti-Tac antibody (50 µg/ml) in Dulbecco's modified Eagle's medium, 10% fetal bovine serum for 30 min at 37 °C. All coverslips were washed 3 times in PBS and fixed for 20 min in 2% formaldehyde in PBS. Internalized mAb 7G7.B6 was detected using LRSC-conjugated goat anti-mouse Ig, and total cellular Tac chimeras were visualized by staining with rabbit anti-Tac and FITC-conjugated goat anti-rabbit Ig as described above.

Sorting Signal Competition Assay-- This was performed essentially as described (50). Tac chimeric proteins were purposefully overexpressed in HeLa cells by transient transfection using 20 µg of plasmid DNA in a 10-cm culture dish. In some experiments, cells were co-transfected with lower levels (0.5 µg) of plasmid DNA encoding Ip33 as a reporter protein. Sixty hours post-transfection, cells were harvested and divided into aliquots for analyses. In some experiments, levels of expression from each of the transfected DNAs was determined by pulse metabolic labeling of 1 aliquot followed by immunoprecipitation. For flow cytometric analysis, 0.5-1 × 106 viable cells were stained with the indicated primary antibodies for 1 h, washed, and then stained with FITC- and PE-conjugated secondary antibodies for an additional hour. Cells were then washed, fixed in 2% formaldehyde in PBS, and analyzed using a Becton Dickinson FACScan (Franklin Lakes, NJ) and CellQuest 1.2 software. Dead cells were excluded from analysis by forward and side scatter measurements. In the analyses shown, cells were gated for those expressing high levels of the "overexpressor" Tac molecule at the cell surface. Transfection efficiencies were monitored by parallel immunofluorescence microscopy analyses.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Tyrosinase Localizes to Late Endosomes and Lysosomes in HeLa Cells-- In order to assess the potential function of conventional sorting signals in the cytoplasmic domain, it was first necessary to determine the ultimate destination of tyrosinase in non-pigmented cells. To this end, tyrosinase was expressed in HeLa cells by transient transfection, and its localization was assessed by indirect immunofluorescence microscopy (IFM).

When expressed at moderate levels, tyrosinase was detected in the nuclear envelope and in reticular and vesicular structures both throughout the cell cytoplasm and in the perinuclear area in most transfected cells (Fig. 2a). Reticular and nuclear envelope staining was variable and more intense at higher levels of expression (data not shown). This staining pattern would be consistent with localization to both the endoplasmic reticulum (ER) and endosomal compartments at steady state. Prominent ER staining is likely a result of slow egress of tyrosinase from the ER due to inefficient folding, supported by pulse/chase analyses in which the half-time for acquisition of resistance to digestion with endoglycosidase H is longer than 1 h.2 To visualize more clearly post-ER compartments, we therefore reduced the pool of newly synthesized, ER-retained tyrosinase by treating transfected cells with the protein synthesis inhibitor, cycloheximide (CHX).


View larger version (84K):
[in this window]
[in a new window]
 
Fig. 2.   Transient expression of wild-type tyrosinase in HeLa cells. HeLa cells were transiently transfected with a plasmid encoding wild-type tyrosinase and fixed 2 days later before (a) or after (b) treatment for 1 h with 50 µg/ml CHX. Permeabilized cells were analyzed by IFM with a rabbit antiserum to tyrosinase (alpha pep7h) and LRSC-conjugated anti-rabbit Ig.

As shown in Fig. 2b, the staining pattern of cells treated for 1 h with CHX was predominantly vesicular. The appearance of tyrosinase in vesicular structures did not require the addition of lysosomal protease inhibitors, suggesting that it is relatively stable to proteolysis within these compartments. To determine the identity of the structures, CHX-treated transfected cells were double-stained with antibodies to tyrosinase and to endogenous endosomal proteins. As shown in Fig. 3, a and b, tyrosinase colocalized with lamp1, a constituent of late endosomes and lysosomes. The staining pattern with both markers was nearly identical in most cells at various expression levels. Near perfect colocalization was also observed with another marker of late endosomes and lysosomes, lamp2, but not with transferrin receptor (early and recycling endosomes), and peripheral tyrosinase+ vesicular structures did not contain the cation-independent mannose 6-phosphate receptor (trans-Golgi network/late endosomes; data not shown). The staining pattern for lamp1 in cells that expressed the transgene did not consistently differ from that in cells that were not transfected, indicating that tyrosinase expression at moderate levels does not alter the morphology of lamp1-positive compartments. We conclude that tyrosinase is directed to conventional late endosomes and lysosomes in HeLa cells. Similar observations were made in CV-1, M1, and 293 cell lines (data not shown).


View larger version (77K):
[in this window]
[in a new window]
 
Fig. 3.   Colocalization of tyrosinase containing wild-type and mutant cytoplasmic domains with lamp1 in HeLa cells. HeLa cells were transiently transfected with plasmids encoding the indicated tyrosinase with either wild-type (a and b) or mutated (c-l) cytoplasmic domains and were analyzed 2 days following transfection by intracellular IFM using a rabbit antiserum to tyrosinase (left), H4A3 to detect endogenous lamp1 (right), and FITC- and LRSC-conjugated secondary antibodies. Prior to fixation, all cells were treated with 50 µg/ml CHX for 1 h at 37 °C. Filled arrowheads point to examples of vesicles in which both tyrosinase and lamp1 were detected. Arrows point to examples of vesicles in which only one protein, but not the other, was stained. Open arrowheads point to larger vesicles with outer rim staining in cells expressing tyrosinase with mutations at Tyr525 (g-j).

Role of Di-leucine and Tyrosine-based Sorting Signals in Localization of Tyrosinase to Late Endosomes and Lysosomes-- To characterize the cytoplasmic sequences responsible for targeting tyrosinase to endosomal compartments, we used site-directed mutagenesis to disrupt critical residues of the putative LL and YXXØ sorting motifs and the additional conserved tyrosine residue Tyr525. Critical residues were altered individually or in combination to alanine (Fig. 1a). Each mutagenized construct was expressed in HeLa cells by transient transfection, and localization was assessed in cells treated with CHX for 1 h by IFM and double staining with antibodies to the tyrosinase transgene and to endogenous lamp1.

Tyrosinase with either or both of the cytoplasmic tyrosine residues disrupted (LL/A/Y, LL/Y/A, and LL/A/A) demonstrated IFM staining patterns similar to that of intact tyrosinase (Fig. 3, e, g, and i). Reticular staining was variable, likely due to differential retention in the ER, and relative staining intensities of given vesicles for lamp1 and tyrosinase were often variable, but the patterns of lamp1- and tyrosinase-containing vesicles were identical for all three mutant forms (arrowheads, Fig. 3, f, h, and j). In contrast, disruption of the putative LL motif alone (AA/Y/Y) or deletion of the cytoplasmic domain (Delta tail-1 and Delta tail-2, data not shown) resulted in a drastic reduction in vesicular staining and the appearance of diffuse staining throughout the cell with intense staining at cell edges, ruffles, and spikes, indicating cell-surface expression (Fig. 3c). Many of the remaining vesicles did not colocalize with lamp1 (arrows, Fig. 3d). Additional mutagenesis of Tyr525 (AA/Y/A) had a small but consistent effect of reducing the level of residual vesicular staining remaining after mutagenesis of the LL motif alone (Fig. 3, k and l, and data not shown). These results indicate that the LL motif in the cytoplasmic domain is necessary for efficient sorting of tyrosinase to late endosomes and lysosomes in HeLa cells. Furthermore, they suggest that the classical tyrosine-based motif, YHSL, plays no direct role in sorting to conventional endosomal organelles but that Tyr525 may be part of a weak secondary sorting signal.

The Tyrosinase Cytoplasmic Domain Is Sufficient to Effect Late Endosomal and Lysosomal Protein Sorting-- In order to rule out a requirement for additional topological determinants that contribute to sorting of tyrosinase, we transferred the cytoplasmic domain alone to a reporter protein, Tac. Tac (the human interleukin-2 receptor alpha  chain) is a monomeric, cell surface, type I integral membrane protein that we have previously used as a reporter to characterize a number of post-Golgi sorting signals (10, 41, 46, 50, 54). A Tac/tyrosinase (TTY) chimera was generated containing the lumenal and transmembrane domains of Tac and the cytoplasmic domain of tyrosinase (Fig. 1b); additional Tac chimeric proteins contained the site-directed mutations of the tyrosinase cytoplasmic domain (Fig. 1b). HeLa cells were transfected with each of the Tac chimeric constructs, and the expressed products were detected by IFM. Since the Tac epitopes detected by our antibodies are sensitive to proteolysis in late endosomes and lysosomes (46, 50, 51), cells were examined after a 4-h treatment with leupeptin.

The results show that TTY behaved similarly to tyrosinase and was localized to vesicular structures that overlapped nearly completely with structures containing lamp1 (Fig. 4, a and b). Furthermore, cells co-transfected with both TTY and tyrosinase and treated with leupeptin demonstrated nearly complete overlap of the two transgenes (data not shown). The staining pattern of TTY was largely dependent on treatment of cells with leupeptin (e.g. see Fig. 5), consistent with degradation of the Tac lumenal domain in proteolytic late endosomal compartments as implicated by parallel pulse/chase experiments (data not shown). The localization of Tac chimeric proteins with altered cytoplasmic tail residues paralleled that of the corresponding tyrosinase mutant; disruption of the LL motif resulted in cell-surface expression (Fig. 4, c and d), whereas disruption of either (not shown) or both tyrosine residues had no or subtle effects (Fig. 4, e and f). Residual vesicles associated with the altered LL motif mutants (TTY-AA/Y/Y and TTY-AA/Y/A) often colocalized with lamp1 (Fig. 4, c and d, and data not shown). Although this result could indicate the existence of a secondary late endosomal sorting signal, the absence of such colocalization with the corresponding full-length tyrosinase constructs would support the alternative conclusion that these vesicles represent the products of normal cell-surface protein turnover made more apparent by leupeptin treatment. Unmodified Tac was expressed only at the cell surface under these conditions (see Fig. 5), and chimeric proteins containing the lumenal or transmembrane domains of tyrosinase without the transmembrane domain were not localized to endosomal compartments (data not shown), suggesting that only the cytoplasmic domain contains independent endosomal sorting information. These data demonstrate that the cytoplasmic domain of tyrosinase is both necessary and sufficient for localization to conventional late endosomes and lysosomes in HeLa cells, and these data confirm the role of the LL motif in efficient endosomal protein sorting.


View larger version (121K):
[in this window]
[in a new window]
 
Fig. 4.   Colocalization of Tac/tyrosinase (TTY) chimeric proteins with lamp1 in HeLa cells. HeLa cells were transiently transfected with plasmids encoding the indicated TTY chimeric proteins with wild-type (a and b) or mutagenized (c-f) cytoplasmic domains and analyzed 2 days post-transfection by intracellular IFM using a rabbit anti-Tac antiserum (left), H4A3 to detect lamp1 (right), and FITC- and LRSC-conjugated secondary antibodies. Prior to fixation, all cells were treated with 1 mg/ml leupeptin for 4 h at 37 °C. Filled arrowheads point to examples of vesicles in which both the Tac lumenal domain and lamp1 were detected. Arrows point to examples of vesicles in which only one protein, but not the other, was stained.


View larger version (73K):
[in this window]
[in a new window]
 
Fig. 5.   The di-leucine motif of tyrosinase functions as an internalization signal. HeLa cells were transiently transfected with plasmids encoding TTY chimeric proteins, Tac, or TTL1 as indicated. Two days later, cells were incubated with 50 µg/ml purified mAb 7G7.B6 in complete medium at 37 °C, and the antibody was allowed to internalize for 30 min. Cells were then fixed and permeabilized, and internalized antibody was detected by IFM using LRSC-conjugated anti-mouse Ig (Int. 7G7.B6). Transfected cells were identified by counterstaining permeabilized cells with rabbit anti-Tac and FITC anti-rabbit Ig (Total Tac chimera). Note that cells were not treated with leupeptin in this experiment.

The Di-leucine Motif of Tyrosinase Functions as an Internalization Signal at the Plasma Membrane-- Most post-Golgi sorting signals also serve as internalization signals that function in efficient retrieval of intracellular proteins from the cell surface. To determine whether the tyrosinase cytoplasmic sorting signals function similarly, we used IFM to assess the ability of the TTY chimeric proteins to effect efficient internalization of anti-Tac antibody in live cells. Chimeric proteins were transiently expressed in HeLa cells at moderate levels, and anti-Tac mAb 7G7.B6 was added to the medium for 30 min at 37 °C to allow antibody uptake prior to fixation. Internalized antibody was detected by staining with anti-mouse immunoglobulin, and total cellular Tac chimeric protein was visualized using a rabbit antiserum. As shown in Fig. 5 (a and b), expression of TTY resulted in the efficient internalization of mAb 7G7.B6 and accumulation in intracellular vesicles. Although the assay was not quantitative, the degree of internalization appeared similar to that of TTL1 which contains the lamp1 cytoplasmic domain (Fig. 5, i and j). Untransfected cells, assessed by lack of staining with rabbit anti-Tac antibody, showed no detectable internalization of the mAb. Furthermore, disruption of either or both of the tyrosine residues in the cytoplasmic domain had no apparent effect on internalization relative to the wild type (Fig. 5, e and f and data not shown). In contrast, disruption of the LL residues dramatically reduced internalization, as evidenced by the intense cell-surface staining from 7G7.B6 in cells transfected with either TTY-AA/Y/Y or TTY-AA/Y/A (Fig. 5, c and d and data not shown). Interestingly, there was a small degree of vesicular 7G7.B6 staining with both of these chimeras that was not visible in cells transfected with Tac alone (Fig. 5, g and h), implicating the existence of a weak internalization signal distinct from the LL motif in the cytoplasmic domain. Taken together, these data suggest that the LL motif in the cytoplasmic domain of tyrosinase is part of a strong internalization signal, and secondary signals may also contribute to internalization. They further imply that tyrosinase may pass through the plasma membrane at some point during its trafficking.

The Di-leucine Signal of Tyrosinase Interacts with Saturable Components Involved in Sorting Mediated by Other Di-leucine- and Tyrosine-based Signals-- By using transient overexpression and a cell-surface displacement assay, we and others (41, 50, 55, 56) have shown that conventional sorting signals that conform to a given motif utilize common saturable components to effect localization but that signals conforming to different motifs utilize distinct saturable components. If the sorting signals in the tyrosinase cytoplasmic domain corresponded to conventional signals, then it would be expected that they would compete for binding sites with endogenous proteins bearing similar signals. Therefore, overexpression of the tyrosinase cytoplasmic domain would result in mis-sorting and displacement of these endogenous proteins to the cell surface. We tested this hypothesis by overexpressing Tac chimeric proteins containing either well described, conventional sorting signals or the cytoplasmic domain of tyrosinase and using flow cytometry to analyze the cell-surface displacement of endogenous or weakly expressed exogenous proteins containing LL or YXXØ motifs. Levels of expression of each Tac chimeric protein were monitored by metabolic labeling and immunoprecipitation, and transfection efficiencies were monitored by IFM.

HeLa cells were transfected with sufficient levels of plasmid DNA encoding Tac chimeric proteins to saturate sorting pathways and appear on the surface of a large fraction of cells. To assay for competition with LL motifs, cells were co-transfected with low levels of plasmid DNA encoding the p33 form of human invariant chain (Ip33). Ip33 contains two well characterized LL-like lysosomal targeting signals in its cytoplasmic domain, DQRDLI and EQLPML (57-60). As shown in Fig. 6a, overexpression of TTY caused displacement of Ip33 to the cell surface at levels comparable to those induced by overexpression of Tac appended with the LL motif from the CD3gamma chain (Tac-DKQTLL; Fig. 6b). As previously shown (50), overexpression of Tac containing no targeting signals (Tac; Fig. 6a) or a functional YXXØ motif (TTL1; Fig. 6b) did not induce significant surface expression of Ip33. Mutagenesis of Tyr521 (TTY-LL/A/Y) did not affect the ability of TTY to displace Ip33 to the cell surface (Fig. 6c). In contrast, alteration of the LL signal (TTY-AA/Y/Y) abolished competition to levels comparable with Tac (Fig. 6c). These data indicate that the LL motifs in the cytoplasmic domains of tyrosinase and Ip33 use common saturable components to effect localization.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 6.   Disruption of sorting mediated by di-leucine-based motifs by overexpression of TTY. HeLa cells were transiently transfected with saturating levels (20 µg/10-cm dish) of plasmids encoding Tac, the indicated Tac chimeras, or a control (Mock) and low levels (0.5 µg/10 cm dish) of a plasmid encoding Ip33. Three days after transfection, cells were harvested and stained for surface expression with a rabbit antibody to Tac, a mouse monoclonal antibody to invariant chain and then FITC-anti-mouse Ig and PE-anti-rabbit Ig. Stained cells were analyzed by flow cytometry. Live cells were gated for high expression of the Tac transgene product (>= 5 × 102 units of fluorescence intensity in PE channel in this experiment) or only for live cells in the Mock sample. Shown is the intensity of FITC staining for gated cells in a representative of three experiments. y axis, cell number (normalized for display purposes); x axis, FITC staining intensity. Parallel analyses of the same cells by metabolic labeling and immunoprecipitation and by immunofluorescence microscopy, as described under "Materials and Methods," showed that all Tac and invariant chain transgene products were expressed to similar levels in this experiment. The peak of cells with no surface staining for Ip33 among transfectants overexpressing TTY, TTY-LL/A/Y, or Tac-DKQTLL is likely due to cells that were transfected with DNA encoding the Tac chimeric product but not Ip33, consistent with the relative transfection efficiencies.

To assay for competition with YXXØ-like sorting signals, we analyzed transfected cells for the cell-surface appearance of two endogenous lysosomal membrane proteins, lamp1 and lamp2. Both proteins rely on well characterized tyrosine-based sorting signals (AGYQTI in lamp1 and AGYEQF in lamp2) to effect late endosomal localization. As shown in Fig. 7, a and d, overexpression of TTY results in significant displacement of both endogenous lamp1 and lamp2 to the cell surface. This displacement is much greater than that observed upon overexpression of Tac-DKQTLL but not as substantial as that induced by overexpression of TTL1; this suggests either a weak affinity for a YXXØ recognition site, a partial steric block to such a site, or competition for a distinct and somewhat less limiting factor. Remarkably, disruption of the LL motif (AA/Y/Y) completely eliminated surface displacement of both lamp1 and lamp2 (Fig. 7, b and e) to levels comparable to that induced by overexpression of Tac with no signal. Thus, competition for YXXØ-based sorting is dependent on the integrity of the tyrosinase LL residues. Disruption of both tyrosines in the tyrosinase cytoplasmic domain (TTY-LL/A/A) reduced, but did not eliminate, cell-surface displacement of both lamp1 and lamp2 (Fig. 7, b and e), suggesting that tyrosine residues influence the ability of the cytoplasmic domain to compete with YXXØ signals. However, the same level of displacement was observed if either tyrosine residue was individually disrupted (LL/Y/A, LL/A/Y; Fig. 7, c and f). This suggests either that both tyrosines take part in a novel sorting signal that weakly or partially competes for cellular factors with conventional YXXØ motifs or that each tyrosine influences the context of the LL motif such that it is now able to block access of cellular components to YXXØ motifs. It further suggests that HeLa cells retain the ability to distinguish structural features of sorting signals in the cytoplasmic domain of tyrosinase from other conventional endosomal sorting signals.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 7.   Disruption of sorting mediated by tyrosine-based motifs by overexpression of TTY. HeLa cells were transiently transfected with saturating levels (20 µg/10 cm dish) of plasmids encoding Tac, the indicated Tac chimeras, or a control (not shown). Three days after transfection, cells were harvested and stained for surface expression with a rabbit antibody to Tac and mouse monoclonal antibodies to endogenous lamp1 (a-c) or lamp2 (d-f), and then FITC-anti-mouse Ig and PE-anti-rabbit Ig. Stained cells were analyzed by flow cytometry. Shown is a representative of four experiments, and data are presented as in Fig. 6. In the experiment shown, TTY, LL/Y/A, LL/A/Y and LL/A/A were expressed at comparable levels and about 2-fold higher than Tac, AA/Y/Y, or Tac-DKQTLL; TTL1 was expressed about half as well as these. In other experiments with similar results, expression levels for all constructs were comparable.

Enlargement of Late Endosomes and Lysosomes by Overexpression of the Di-leucine Signal of Tyrosinase but Not of CD3gamma -- When cells overexpressing TTY were analyzed by IFM, the TTY product was observed to accumulate not only at the cell surface but also in the periphery of large vesicular structures, the lumen of which was clearly visible (Fig. 8a). Comparison of lamp1 staining revealed a concomitant enlargement of lamp1-positive compartments in cells overexpressing TTY relative to untransfected cells (Fig. 8b). Similarly enlarged lamp1-positive structures were observed in cells overexpressing full-length tyrosinase (Fig. 8, i and j). These structures accumulated more in the perinuclear area than in distal regions of the cell. Measurement of lamp1-positive structures in untransfected cells or cells expressing high levels of TTY at the cell surface revealed a 2-fold increase in diameter in the latter cells (1.026-µm median diameter), representing a 4-fold increase in surface area, relative to the untransfected cells (0.498 µm median diameter; see Table I). This difference was statistically significant (p < 0.0001). Enlargement of lamp1-positive compartments was also observed upon overexpression of TTY-LL/A/A (Fig. 8, e and f), TTY-LL/Y/A and TTY-LL/A/Y (not shown), but not of TTY-AA/Y/Y (Fig. 8, c and d) or tyrosinase-AA/Y/Y (Fig. 8, k and l), indicating that the enlargement was dependent on the integrity of the LL motif but not of either or both tyrosine residues. Importantly, overexpression of comparably high levels of Tac-DKQTLL, with the LL motif from CD3gamma , failed to induce a dramatic enlargement of lamp1-positive structures (0.573 µm median diameter), although there was a statistically significant difference in comparison to untransfected cells (0.498 µm median diameter; p < 0.0001) (Fig. 8, g and h, and Table I). The massive enlargement observed upon overexpression of TTY is likely due to disruption of sorting of a protein(s) required for maintenance of late endosomal volume or surface area. These results suggest that the LL signal of tyrosinase mediates sorting through a common pathway with such a protein, whereas the LL signal of CD3gamma does not. We conclude, therefore, that these two signals direct sorting to late endosomes via distinct pathways.


View larger version (83K):
[in this window]
[in a new window]
 
Fig. 8.   Overexpression of the tyrosinase cytoplasmic domain induces an enlargement of lamp1-positive vesicular structures. HeLa cells were transfected with saturating levels (8 µg/60-mm dish) of plasmid encoding TTY (a and b), TTY-AA/Y/Y (c and d), TTY-LL/A/A (e and f), Tac-DKQTLL (g and h), tyrosinase (i and j), or tyrosinase-AA/Y/Y (k and l). Three days after transfection, coverslips were fixed and analyzed by IFM using antibodies to Tac (a, c, e, and g) or tyrosinase (i and k) and lamp1 (right panels). All cells are shown at the same level of magnification. Inset shows a higher magnification of lamp1 staining of Tac positive cells to emphasize the relative sizes of the lamp1-positive compartments. Transfection efficiencies were monitored by counting the fraction of Tac expressing cells, and aliquots of cells were also subjected to metabolic pulse labeling and immunoprecipitation to determine expression levels. Expression per cell, determined as described under "Materials and Methods," was comparable among all Tac chimeric samples (relative expression: TTY, 1.0; Tac-DKQTLL, 1.04; TTY-AA/Y/Y, 1.38; TTY-LL/A/A, 1.34) and among both tyrosinase samples (relative expression: tyrosinase, 1.0; tyrosinase-AA/Y/Y, 2.88).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Increased diameter of lamp1-positive compartments in cells overexpressing the tyrosinase cytoplasmic domain
HeLa cells transfected with high doses of plasmid encoding TTY or Tac-DKQTLL were analyzed by IFM as in Fig. 8. The diameter of individual lamp1-positive vesicles in untransfected cells or cells overexpressing (surface expression) TTY or Tac-DKQTLL was measured using OpenLab software; for elliptical or irregular vesicles, lines were drawn through the longest axis to measure an apparent diameter. Median values are expressed in µm. Number in parentheses indicates the number of vesicles used for the measurements.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The mechanisms by which proteins are localized to tissue-specific organelles are poorly understood, but in many cases they may take advantage of existing redundant pathways to ubiquitous organelles. We (10) and others (9, 11-13) have previously described evidence that multiple pathways exist for protein transport to late endosomes and lysosomes, providing the potential for subversion of one pathway for localization to tissue-specific late endosomal organelles. Here, we have extended these studies to demonstrate that a distinct type of LL-based late endosomal/lysosomal sorting signal exists in the cytoplasmic domain of tyrosinase, an integral membrane protein component of the melanosome. The singular behavior of the tyrosinase sorting signals in non-pigmented cells provides a potential mechanism by which these signals might be distinguished for localization to the unique, late endosome-like melanosome in melanocytic cells.

Tyrosinase Localizes to Late Endosomes and Lysosomes of Non-pigmented Cells-- The cytoplasmic domain of tyrosinase proved to be both necessary and sufficient for localization to conventional late endosomes and lysosomes of non-pigmented cells, suggesting that it contains a classical late endosomal/lysosomal sorting determinant. This was evidenced by nearly complete colocalization of full-length tyrosinase or the TTY chimeric protein with lamp1 and lamp2 in transfected cells, and by predominant cell-surface expression upon mutagenesis of the LL motif or deletion of the cytoplasmic domain. Our immunolocalization data extend previous observations in which products of tyrosinase activity co-fractionated with lysosomes or lysosome-like structures in transfected cells (Refs. 61-63 and reviewed in Refs. 21 and 23). A requirement for the cytoplasmic domain in proper localization is consistent with the trafficking defects of the murine cP allele (30), the OCA phenotype of human patients with a mutation rendering loss of the cytoplasmic domain (31), and properties of the cytoplasmic domain of the tyrosinase-related protein TRP-1 (37).

Like other classical late endosomal sorting signals, the cytoplasmic domain of tyrosinase also directed internalization and late endosomal localization from the plasma membrane, since anti-Tac antibody was internalized and delivered to vesicular compartments in cells expressing TTY. This is the first described indication that melanosomal proteins may be internalized and is consistent with previously reported observations that a fraction of TRP-1 resides at the plasma membrane (64) and that endocytosed albumin-gold conjugates can be found in melanosomes (22). If the cytoplasmic domain of tyrosinase functions similarly in cells of the melanocytic lineage, such recycling might serve to preserve cellular tyrosinase levels in the face of ongoing secretion of melanin.

A Second Class of Di-leucine-based Sorting Signals-- A role for LL-based signals in melanosomal protein localization was first implied by the loss of intracellular localization of the tyrosinase-related protein, TRP-1, in fibroblasts and melanocytes upon carboxyl-terminal truncation that eliminated a sequence overlapping a LL-like signal (37). In vitro binding of a LL motif from the mouse tyrosinase cytoplasmic domain to the adaptor-like protein complex, AP3, lent further indirect support to a critical role for LL signals (38). Our point mutagenesis studies clearly showed that efficient internalization and steady state localization of human tyrosinase to late endosomes and lysosomes is dependent on two consecutive leucine residues that lie within a sequence conforming to a classical LL motif (35, 51, 65). Somewhat surprisingly, mutagenesis of either of two conserved tyrosine residues (Tyr521 or Tyr525), one of which (Tyr521) lies within a consensus YXXØ motif, had only minimal effects on steady state localization and internalization. Furthermore, these residues were unable to sustain localization of full-length tyrosinase to late endosomes or lysosomes in the absence of a functional LL motif. These data show that the LL residues of tyrosinase, but not the tyrosine residues, are critical components of a sorting determinant for late endosomes and lysosomes.

The results of an in vivo competition assay suggest that the critical LL residues form the foundation for a LL motif-based sorting signal but that this signal interacts either with unique limiting cellular components or with common LL-binding components in a unique manner. In this assay, overexpression of TTY resulted in extensive displacement from intracellular stores to the cell surface of the invariant chain, a protein that relies on two LL-like motifs for its sorting to late endosomes (57-59). This displacement was as effective as that achieved upon overexpression of a chimeric protein containing the LL signal from CD3gamma (51) and was much greater than that observed with the YXXØ signal from lamp1 as previously shown (50). We conclude from these results that TTY effectively competes for limiting cellular factors in sorting and internalization mediated by well characterized LL motifs. However, overexpression of TTY also resulted in significant cell-surface displacement of lamp1 and lamp2, two proteins that rely on YXXØ signals for lysosomal sorting and internalization. This displacement was not as great as that induced by overexpression of the lamp1 YXXØ signal, but was much greater than that induced by overexpression of Tac alone or of the LL signal from CD3gamma . We interpret this displacement as an indication that TTY partially competes for limiting cellular factors involved in either the recognition of YXXØ signals or sorting and internalization mediated by these signals. Importantly, induction of lamp1 and lamp2 surface expression was ablated by mutagenesis of the LL residues, indicating that competition for YXXØ signals was dependent on the integrity of the LL motif. This interaction with YXXØ-based recognition/sorting factors represents a novel property of a LL-based sorting signal, since competition for YXXØ motifs is not observed with the CD3gamma LL signal (here and Ref. 50). The data therefore suggest that the tyrosinase LL-based signal interacts with at least partially distinct factors to direct sorting to late endosomes and lysosomes in HeLa cells.

A second indication of the distinctive nature of the tyrosinase sorting signal came from IFM analysis of overexpressing cells. Overexpression of TTY or tyrosinase induced enlargement of lamp1-positive late endosomes and lysosomes in HeLa cells, whereas expression of comparably high levels of Tac-DKQTLL (with the CD3gamma LL signal) had no such effect. This effect was dependent on the LL residues of the tyrosinase cytoplasmic domain but not the distal tyrosine residues. The enlargement could be due to either accumulation of lumenal contents (failure to degrade lumenal contents), disregulation of ion transport across the late endosomal membrane (increased lumenal ionic strength to cause swelling), or failure to form vesicles from the limiting membrane (inhibition of budding), any of which most likely results from competitive inhibition of a specific sorting step for a protein critical in each process by overexpression of the tyrosinase, but not the CD3gamma , LL signal. Interestingly, similar observations have been made upon overexpression of the invariant chain (66, 67). The sequence of the membrane proximal of the two LL-like signals in invariant chain is similar to that of tyrosinase (57, 59, 60, 68), suggesting that both proteins may be sorted by similar mechanisms.

Influence of Tyrosine Residues on Context of the Di-leucine Signal-- Although the tyrosine residues Tyr521 and Tyr525 do not appear to contribute significantly to signals with intrinsic sorting activity in HeLa cells, our competition results suggest that they may contribute to the context in which the LL motif is recognized. This was evident by the partial reduction in the ability of overexpressed TTY to displace lamp1 and lamp2 to the surface upon mutagenesis of either Tyr521, Tyr525, or both. The partial but not additive effects of these mutations on lamp displacement indicates that either (i) both tyrosines are part of a secondary targeting signal, the activity of which is dependent on the LL motif, or (ii) both tyrosines influence the context of the LL signal such that it can block the interaction of cellular factors with YXXØ motifs. Since there is no precedent for either a targeting signal with two critical tyrosines in the indicated positions or a signal that acts only at an endosomal site and not at the cell surface, we favor the second model. Regardless of the mechanism, our data represent the first documented modification of the properties of an LL sorting motif by a membrane distal sequence and add to the described effects of membrane proximal residues on LL sorting efficacy (35, 60, 69-71).

We speculate that the context of the LL motif could be affected by the tyrosine residues either by an induced conformation that sterically blocks access to a separate YXXØ-binding site on a putative LL receptor or to altered specificity for a LL receptor in which binding sites for LL and YXXØ motifs are spatially closer than in the receptor for the CD3gamma LL motif. Distinct receptors for each LL motif might provide a mechanism by which their differential sorting can be effected, consistent with the morphological characteristics of the TTY- and tyrosinase-overexpressing cells. Potential candidates for such LL receptors would be the adaptor complexes AP3, AP2, and AP1; the LL motifs of mouse tyrosinase and CD3gamma have been described to bind, respectively, to AP3 and AP2/AP1 (38, 72). The affinity of a given signal for different AP complexes has been proposed to regulate sorting at different sites within the endosomal pathway (25, 34, 36, 73, 74); thus, we would predict that differential binding, influenced by the tyrosine residues, would result in distinct localization pathways for similar steady state distributions of these two proteins.

Implications for Melanosomal Protein Sorting-- We (data not shown) and others (reviewed in Refs. 21 and 23) have observed differential localization of lamp1 and tyrosinase in some melanocytes and melanoma cells, suggesting that melanosomal and late endosomal integral membrane proteins are differentially recognized by the melanocyte protein sorting machinery. Our results here provide a potential mechanism to account for this differential recognition. It is conceivable that the cellular effectors that interact with the LL signal from tyrosinase and facilitate sorting via a unique pathway to late endosomes in HeLa cells may be usurped by cells of the melanocyte lineage to direct proteins such as tyrosinase and TRP-1 to melanosomes. Sequence comparison of tyrosinase, TRP-1, and TRP-2 from several species shows a striking conservation of general structural features of the cytoplasmic domain that would be consistent with recognition by a distinct sorting receptor (Fig. 9). First, each of these proteins retains a LL- (tyrosinase and TRP-1) or GYXXØ-based (TRP-2) late endosomal/lysosomal sorting signal at a conserved position close to the membrane. Second, each protein, particularly tyrosinase, has an unusually high content of basic residues in the membrane proximal region, amino-terminal to the lysosomal sorting signal. These residues could interact with acidic headgroups of phospholipids and/or with a third conserved region of the cytoplasmic domains rich in acidic amino acid residues and distal to the conventional sorting signal. If these two regions were to interact three-dimensionally, a conserved tyrosine residue, analogous to Tyr525 in human tyrosinase, could be placed in close proximity to the conventional sorting signal where it might be able to affect interactions with APs. Although highly speculative, this model creates a conceptual framework with which to test functions of different regions of the cytoplasmic domains of tyrosinase, TRP-1, and TRP-2 in melanosomal protein sorting.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 9.   Sequence alignment of the cytoplasmic domains of tyrosinase and tyrosinase-related proteins from different species. Shown are the deduced amino acid sequences of the predicted cytoplasmic domains from the indicated proteins, aligned into regions as defined in the text. Basic residues within the membrane proximal region are indicated in bold; consensus sorting signals are underlined; acidic residues in the distal region are shaded, and the conserved tyrosine residue is boxed. Sequences were obtained from the GenBankTM data base.

It is particularly intriguing that a determinant capable of mediating specialized localization in pigmented cells effects localization to conventional late endosomes and lysosomes in the inappropriate cell type. The cell type-specific appropriation of a secondary ubiquitous sorting pathway for a specific localization pattern is well established. Proteins that are differentially sorted to basolateral and apical surfaces in polarized cells are delivered to the same cell-surface domain of fibroblasts in separate vesicles (14-16). Furthermore, yeast use two pathways for protein delivery to the vacuole, including one that is dependent on recognition of LL-like motifs by the homologue of AP3 (1). Thus, further understanding of the mechanisms of melanosomal protein sorting should provide insights into general pathways of transport to specialized late endosomal compartments.

    ACKNOWLEDGEMENTS

We gratefully acknowledge Drs. V. Hearing (National Institutes of Health, Bethesda), W. Storkus (University of Pittsburgh), and S. Topalian (National Institutes of Health) for generously providing reagents and guidance for analysis of tyrosinase. We also thank Drs. M. Fukuda (Scripps Institute, La Jolla, CA), L. Old (Ludwig Institute, New York), H. Hansen (Immunomedics, Morris Plains, NJ), and T. Braulke (University of Göttingen, Göttingen, Germany) for providing necessary reagents; Dr. D. Roof (University of Pennsylvania) for use of the microscope facility; Dr. C. Deutsch (University of Pennsylvania) for assistance with statistical analyses; and Dr. W. Skach (University of Pennsylvania), Dr. M. Birnbaum (University of Pennsylvania), Dr. J. Keen (Thomas Jefferson University, Philadelphia), and Shaheen Sutterwala for critical review of the manuscript.

    Note Added in Proof

During review of this manuscript, Simmen et al. (Simmon, T., Schmidt, A., Hunziker, W., and Beermann. F. (1999) J. Cell Sci. 112, 45-53) published a characterization of cytoplasmic domain signals required for lysosomal targeting of murine tyrosinase in transfected MDCK cells. They found a similar requirement for the LL motif. However, their mutational analysis (but not their deletion analysis) implicated the proximal tyrosine residue as also necessary for targeting. We feel that the data are consistant with our interpretation of a role for the tyrosine residue in regulating the conformation of the LL motif; mouse tyrosinase contains an additional leucine residue following the YXXØ motif (the sequence is YHSLL), and we speculate that mutagenesis of the tyrosine results in an inappropriate hydrophobic interaction of these two leucine residues with the bona fide LL motif, resulting in its functional inactivation.

    FOOTNOTES

* This work was supported in part by Grant RPG 97-003-01-BE from the American Cancer Society and Grants R21 AI 42055 and R21 AI 42617 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported in part by a National Research Service Award 1F32-AI09946 and by Training Grant T32-CA09671 from the National Institutes of Health.

§ Supported in part by Training Grant T32-EY07131-06 from the National Institutes of Health.

To whom correspondence should be addressed: Dept. of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, 277 John Morgan Bldg./6082, 36th and Hamilton Walk, Philadelphia, PA 19104-6082. Tel.: 215-898-3204; Fax: 215-573-4345; E-mail: marksm{at}mail.med.upenn.edu.

2 J. F. Berson, D. W. Frank, P. A. Calvo, B. M. Bieler, and M. S. Marks, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: OCA, oculocutaneous albinism; Ø, amino acid with bulky hydrophobic side chain; LL, di-leucine; YXXØ, tyrosine-based motif; AP, adaptor-like complex; TRP, tyrosinase-related protein; mAb, monoclonal antibody; IFM, immunofluorescence microscopy; CHX, cycloheximide; FITC, fluorescein isothiocyanate; LRSC, lissamine rhodamine-sulfonyl chloride; PE, phycoerythrin; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; ER, endoplasmic reticulum.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
  1. Odorizzi, G., Cowles, C. R., and Emr, S. D. (1998) Trends Cell Biol. 8, 282-288[CrossRef][Medline] [Order article via Infotrieve]
  2. Kirchhausen, T., Bonifacino, J. S., and Reizman, H. (1997) Curr. Opin. Cell Biol. 9, 488-495[CrossRef][Medline] [Order article via Infotrieve]
  3. Piper, R. C., Bryant, N. J., and Stevens, T. H. (1997) J. Cell Biol. 138, 531-545[Free Full Text]
  4. Cowles, C. R., Snyder, W. B., Burd, C. G., and Emr, S. D. (1997) EMBO J. 16, 2768-2782
  5. Vowels, J. J., and Payne, G. S. (1998) EMBO J. 17, 2482-2493[Abstract/Free Full Text]
  6. Darsow, T., Burd, C. G., and Emr, S. D. (1998) J. Cell Biol. 142, 913-922[Abstract/Free Full Text]
  7. Tan, P. K., Howard, J. P., and Payne, G. S. (1996) J. Cell Biol. 135, 1789-1800[Abstract]
  8. Cooper, A. A., and Stevens, T. H. (1996) J. Cell Biol. 133, 529-541[Abstract]
  9. Peters, P. J., Neefjes, J. J., Oorschot, V., Ploegh, H. L., and Geuze, H. J. (1991) Nature 349, 669-676[CrossRef][Medline] [Order article via Infotrieve]
  10. Liu, S.-H., Marks, M. S., and Brodsky, F. M. (1998) J. Cell Biol. 140, 1023-1037[Abstract/Free Full Text]
  11. Glickman, J. N., Morton, P. A., Slot, J. W., Kornfeld, S., and Geuze, H. J. (1996) J. Cell Biol. 132, 769-785[Abstract]
  12. Song, W., Wagle, N. M., Banh, T., Whiteford, C. C., Ulug, E., and Pierce, S. K. (1997) Int. Immunol. 9, 1709-1722[Abstract]
  13. Karlsson, K., and Carlsson, S. R. (1998) J. Biol. Chem. 273, 18966-18973[Abstract/Free Full Text]
  14. Yoshimori, T., Keller, P., Roth, M. G., and Simons, K. (1996) J. Cell Biol. 133, 247-256[Abstract]
  15. Wilson, J. M., and Colton, T. L. (1997) J. Cell Biol. 136, 319-330[Abstract/Free Full Text]
  16. Gut, A., Kappeler, F., Hyka, N., Balda, M. S., Hauri, H. P., and Matter, K. (1998) EMBO J. 17, 1919-1929[Free Full Text]
  17. Keller, P., and Simons, K. (1997) J. Cell Sci. 110, 3001-3009[Abstract/Free Full Text]
  18. Seiji, M., Fitzpatrick, T. B., and Birbeck, M. S. C. (1961) J. Invest. Dermatol. 36, 243-252
  19. King, R. A., Hearing, V. J., Creel, D. J., and Oetting, W. S. (1995) in The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds), Vol. 3, pp. 4353-4392, McGraw-Hill Inc., New York
  20. Diment, S., Eidelman, M., Rodriguez, G. M., and Orlow, S. J. (1995) J. Biol. Chem. 270, 4213-4215[Abstract/Free Full Text]
  21. Orlow, S. J. (1995) J. Invest. Dermatol. 105, 3-7[Abstract]
  22. Schraermeyer, U. (1995) Pigm. Cell Res. 8, 209-214[Medline] [Order article via Infotrieve]
  23. Schraermeyer, U. (1996) Histol. Histopathol. 11, 445-462[Medline] [Order article via Infotrieve]
  24. Jackson, I. J. (1997) Hum. Mol. Genet. 6, 1613-1624[Abstract/Free Full Text]
  25. Kantheti, P., Qiao, X., Diaz, M. E., Peden, A. A., Meyer, G. E., Carskadon, S. L., Kapfhamer, D., Sufalko, D., Robinson, M. S., Noebels, J. L., and Burmeister, M. (1998) Neuron 21, 111-122[Medline] [Order article via Infotrieve]
  26. Orlow, S. J., Boissy, R. E., Moran, D. J., and Pifko-Hirst, S. (1993) J. Invest. Dermatol. 100, 55-64[Abstract]
  27. Kwon, B. S., Haq, A. K., Pomerantz, S. H., and Halaban, R. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 7473-7477[Abstract]
  28. del Marmol, V., and Beermann, F. (1996) FEBS Lett. 381, 165-168[CrossRef][Medline] [Order article via Infotrieve]
  29. King, R. A., Mentink, M. M., and Oetting, W. S. (1991) Mol. Biol. & Med. 8, 19-29[Medline] [Order article via Infotrieve]
  30. Beermann, F., Orlow, S. J., Boissy, R. E., Schmidt, A., Boissy, Y. L., and Lamoreux, M. L. (1995) Exp. Eye Res. 61, 599-607[Medline] [Order article via Infotrieve]
  31. Giebel, L. B., Tripathi, R. K., Strunk, K. M., Hanifin, J. M., Jackson, C. E., King, R. A., and Spritz, R. A. (1991) Am. J. Hum. Genet. 48, 1159-1167[Medline] [Order article via Infotrieve]
  32. Trowbridge, I. S., Collawn, J. F., and Hopkins, C. R. (1993) Annu. Rev. Cell Biol. 9, 129-161[CrossRef]
  33. Sandoval, I. V., Arredondo, J. J., Alcalde, J., Gonzalez Noriega, A., Vandekerckhove, J., Jimenez, M. A., and Rico, M. (1994) J. Biol. Chem. 269, 6622-6631[Abstract/Free Full Text]
  34. Bonifacino, J. S., Marks, M. S., Ohno, H., and Kirchhausen, T. (1996) Proc. Assoc. Amer. Physicians 108, 285-295[Medline] [Order article via Infotrieve]
  35. Pond, L., Kuhn, L. A., Teyton, L., Schutze, M.-P., Tainer, J. A., Jackson, M. R., and Peterson, P. A. (1995) J. Biol. Chem. 270, 19989-19997[Abstract/Free Full Text]
  36. Marks, M. S., Ohno, H., Kirchhausen, T., and Bonifacino, J. S. (1997) Trends Cell Biol. 7, 124-128[CrossRef]
  37. Vijayasaradhi, S., Xu, Y. Q., Bouchard, B., and Houghton, A. N. (1995) J. Cell Biol. 130, 807-820[Abstract]
  38. Höning, S., Sandoval, I. V., and von Figura, K. (1998) EMBO J. 17, 1304-1314[Abstract/Free Full Text]
  39. Jiménez, M., Tsukamoto, K., and Hearing, V. J. (1991) J. Biol. Chem. 266, 1147-1156[Abstract/Free Full Text]
  40. Chen, Y. T., Stockert, E., Tsang, S., Coplan, K. A., and Old, L. J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8125-8129[Abstract]
  41. Santini, F., Marks, M. S., and Keen, J. H. (1998) Mol. Biol. Cell 9, 1177-1194[Abstract/Free Full Text]
  42. Hansen, H. J., Ong, G. L., Diril, H., Valdez, A., Roche, P. A., Griffiths, G. L., Goldenberg, D. M., and Mattes, M. J. (1996) Biochem. J. 320, 293-300[Medline] [Order article via Infotrieve]
  43. Lamb, C. A., and Cresswell, P. (1992) J. Immunol. 148, 3478-3482[Abstract/Free Full Text]
  44. Carlsson, S. R., Roth, J., Piller, F., and Fukuda, M. (1988) J. Biol. Chem. 263, 18911-18919[Abstract/Free Full Text]
  45. Fukuda, M., Viitala, J., Matteson, J., and Carlsson, S. R. (1988) J. Biol. Chem. 263, 18920-18928[Abstract/Free Full Text]
  46. Marks, M. S., Roche, P. A., van Donselaar, E., Woodruff, L., Peters, P. J., and Bonifacino, J. S. (1995) J. Cell Biol. 131, 351-369[Abstract]
  47. Bonifacino, J. S., Suzuki, C. K., and Klausner, R. D. (1990) Science 247, 79-82[Medline] [Order article via Infotrieve]
  48. Roche, P. A., Teletski, C. L., Karp, D. R., Pinet, V., Bakke, O., and Long, E. O. (1992) EMBO J. 11, 2841-2847[Abstract]
  49. Rutledge, T., Cosson, P., Manolios, N., Bonifacino, J. S., and Klausner, R. D. (1992) EMBO J. 11, 3245-3254[Abstract]
  50. Marks, M. S., Woodruff, L., Ohno, H., and Bonifacino, J. S. (1996) J. Cell Biol. 135, 341-354[Abstract]
  51. Letourneur, F., and Klausner, R. D. (1992) Cell 69, 1143-1157[Medline] [Order article via Infotrieve]
  52. Higuchi, R., Krummel, B., and Saiki, R. K. (1988) Nucleic Acids Res. 16, 7351-7367[Abstract]
  53. Humphrey, J. S., Peters, P. J., Yuan, L. C., and Bonifacino, J. S. (1993) J. Cell Biol. 120, 1123-1135[Abstract]
  54. Voorhees, P., Deignan, E., van Donselaar, E., Humphrey, J., Marks, M. S., Peters, P. J., and Bonifacino, J. S. (1995) EMBO J. 14, 4961-4975[Abstract]
  55. Warren, R. A., Green, F. A., and Enns, C. A. (1997) J. Biol. Chem. 272, 2116-2121[Abstract/Free Full Text]
  56. Warren, R. A., Green, F. A., Stenberg, P. E., and Enns, C. A. (1998) J. Biol. Chem. 273, 17056-17063[Abstract/Free Full Text]
  57. Pieters, J., Bakke, O., and Dobberstein, B. (1993) J. Cell Sci. 106, 831-846[Abstract/Free Full Text]
  58. Simonsen, A., Momburg, F., Drexler, J., Hammerling, G. J., and Bakke, O. (1993) Int. Immunol. 5, 903-917[Abstract]
  59. Odorizzi, C. G., Trowbridge, I. S., Xue, L., Hopkins, C. R., Davis, C. D., and Collawn, J. F. (1994) J. Cell Biol. 126, 317-330[Abstract]
  60. Kang, S., Liang, L., Parker, C. D., and Collawn, J. F. (1998) J. Biol. Chem. 273, 20644-20652[Abstract/Free Full Text]
  61. Bouchard, B., Fuller, B. B., Vijayasaradhi, S., and Houghton, A. N. (1989) J. Exp. Med. 169, 2029-2042[Abstract]
  62. Kondoh, H., Wilczek, A., Narimizu, S., and Mishima, Y. (1996) Zool. Sci. 13, 825-831[Medline] [Order article via Infotrieve]
  63. Borovansky, J., Mommaas, A. M., Smit, N. P., Eygendaal, D., Winder, A. J., Vermeer, B. J., and Pavel, S. (1997) Arch. Dermatol. Res. 289, 145-150[CrossRef][Medline] [Order article via Infotrieve]
  64. Xu, Y., Setaluri, V., Takechi, Y., and Houghton, A. N. (1997) J. Invest. Dermatol. 109, 788-795[Abstract]
  65. Johnson, K. F., and Kornfeld, S. (1992) J. Biol. Chem. 267, 17110-17115[Abstract/Free Full Text]
  66. Romagnoli, P., Layet, C., Yewdell, J., Bakke, O., and Germain, R. N. (1993) J. Exp. Med. 177, 583-596[Abstract]
  67. Arunachalam, B., Lamb, C. A., and Cresswell, P. (1993) Int. Immunol. 6, 439-451[Abstract]
  68. Odorizzi, G., and Trowbridge, I. S. (1997) J. Biol. Chem. 272, 11757-11762[Abstract/Free Full Text]
  69. Dietrich, J., Hou, X., Wegener, A.-M. K., and Geisler, C. (1994) EMBO J. 13, 2156-2166[Abstract]
  70. Dittrich, E., Haft, C. R., Muys, L., Heinrich, P. C., and Graeve, L. (1996) J. Biol. Chem. 271, 5487-5494[Abstract/Free Full Text]
  71. Geisler, C., Dietrich, J., Nielsen, B. L., Kastrup, J., Lauritsen, J. P. H., Ødum, N., and Christensen, M. D. (1998) J. Biol. Chem. 273, 21316-21323[Abstract/Free Full Text]
  72. Dietrich, J., Kastrup, J., Nielsen, B. L., Ødum, N., and Geisler, C. (1997) J. Cell Biol. 138, 271-281[Abstract/Free Full Text]
  73. Robinson, M. S. (1997) Trends Cell Biol. 7, 99-102[CrossRef]
  74. Seymour, A. S., Feng, L., Novak, E. K., Robinson, M. S., and Swank, R. T. (1997) Mol. Biol. Cell 8, 227 (Abstr.)


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.